TABLE 3.
Comparison of the levels of BTMs and BMD between groups
| Variables | NTOVCF (n = 208) | Control (n = 220) | P value |
|---|---|---|---|
| P1NP (ng/ml) a | 46.58 ± 28.57 | 50.75 ± 20.67 | 0.086 |
| β‐CTX (ng/ml) a | 0.89 ± 0.65 | 0.57 ± 0.30 | 0.000 |
| N‐MID (ng/ml) a | 18.72 ± 11.81 | 19.16 ± 8.51 | 0.664 |
| ALP (U/L) a | 74.38 ± 19.72 | 76.57 ± 20.11 | 0.257 |
| ACP (U/L) a | 8.82 ± 1.23 | 8.21 ± 1.11 | 0.000 |
| NACP (U/L) a | 4.71 ± 0.70 | 4.13 ± 0.61 | 0.000 |
| PACP (U/L) a | 4.11 ± 0.67 | 4.08 ± 0.63 | 0.656 |
| PTH (pg/ml) a | 28.31 ± 17.28 | 38.11 ± 20.17 | 0.000 |
| 25(OH)D (ng/ml) a | 21.93 ± 8.39 | 24.82 ± 8.50 | 0.000 |
| Calcium (mmol/L) a | 2.24 ± 0.15 | 2.26 ± 0.14 | 0.092 |
| Phosphorus (mmol/L) a | 1.12 ± 0.19 | 1.11 ± 0.17 | 0.643 |
| Magnesium (mmol/L) a | 0.85 ± 0.09 | 0.87 ± 0.08 | 0.135 |
| β‐CTX/P1NP (%) a | 2.51 ± 2.59 | 1.18 ± 0.60 | 0.000 |
| BMD (T‐score) a | −3.48 ± 0.47 | −3.07 ± 0.44 | 0.000 |
| First‐degree (n) b | 91 (43.8%) | 175 (79.5%) | 0.000 |
| Second‐degree (n) b | 86 (41.3%) | 36 (16.4%) | |
| Third‐degree (n) b | 31 (14.9%) | 9 (4.1%) |
Abbreviations: β‐CTX, b‐C‐terminal telopeptide of type I collagen; ACP, acid phosphatase; ALP, alkaline phosphatase; BMD, bone mineral density; NACP, non‐prostatic acid phosphatase; N‐MID, N‐terminal middle segment osteocalcin; PACP, prostatic acid phosphatase; P1NP, propeptide of type I procollagen; PTH, Parathyroid Hormone.
a
Notes: Values were expressed as mean ± SD and evaluated by the student's t‐test.
b
Values were expressed as numbers and compared using a Chi‐square test.